Board of Hester Biosciences approves investment in subsidiary
On 07 June 2017
Hester Biosciences announced that the Company's Board of Directors have decided and approved to make an investment in its wholly owned subsidiary Company namely Hester Biosciences Africa, incorporated in the Tanzania, Africa, to the extent of USD 3 million. The main business of the wholly owned subsidiary Company will be of Manufacturing and Trading of Veterinary Vaccines and Health Products.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content